Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.733 USD | +7.30% | -2.74% | -48.21% |
27/03 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
26/03 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.21% | 32.96M | |
+73.22% | 12.38B | |
-20.44% | 7.92B | |
+15.69% | 7.2B | |
+6.78% | 5.84B | |
+7.49% | 5.07B | |
+23.97% | 4.53B | |
-21.67% | 3.88B | |
-40.96% | 2.23B | |
+1.24% | 2.02B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Cantor Fitzgerald Starts Lucid Diagnostics at Overweight With $21 Price Target